Combination drug therapy for childhood brain tumors shows promise in laboratory models
In experiments with human cells and mice, researchers at the Johns Hopkins Kimmel Cancer Center report evidence that combining the experimental cancer medication TAK228 (also called sapanisertib) with an existing anti-cancer ...
Feb 17, 2020
0
77